This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Ausgewählte Literatur
Alessandria C, Ottobrelli A, Debernardi-Venon W et al (2007) Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study. J Hepatol 47:499–505
Arroyo V, Fernandez J, Gines P (2008) Pathogenesis and treatment of hepatorenal syndrome. Semin Liver Dis 28:81–95
Banares R, Nevens F, Larsen FS et al (2013) Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial. Hepatology 57:1153–1162
Begriche K, Massart J, Robin MA et al. (2011) Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver. J Hepatol 54:773–794
Bernal W (2003) Intensive care support therapy. Liver Transpl 9:15–17
Bernal W, Auzinger G, Dhawan A et al. (2010) Acute liver failure. Lancet 376: 190 – 201
Biancofiore G, Auzinger G, Mandell S et al (2012) Liver cirrhosis in the medical critical care patient. Minerva Anestesiol 78:693–703
Broussard CN, Aggarwal A, Lacey SR et al (2001) Mushroom poisoning – from diarrhea to liver transplantation. Am J Gastroenterol 96:3195–3198
Brunnenberg T, Cicinnati VR, Schmidt HHJ (2013) Akutes Leberversagen. Intensivmedizin up2date 8:145–155
Das V, Boelle PY, Galbois A et al (2010) Cirrhotic patients in the medical intensive care unit: early prognosis and long-term survival. Crit Care Med 38:2108–2116
Eefsen M, Dethloff T, Frederiksen HJ et al (2007) Comparison of terlipressin and noradrenalin on cerebral perfusion, intracranial pressure and cerebral extracellular concentrations of lactate and pyruvate in patients with acute liver failure in need of inotropic support. J Hepatol 47:381–386
Fernandez J, Monteagudo J, Bargallo X et al (2005) A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis. Hepatology 42:627–634
Fernandez J, Navasa M, Planas R et al. (2007) Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis. Gastroenterology 133:818–824
Gines P, Torre A, Terra C, Guevara M (2004) Review article: pharmacological treatment of hepatorenal syndrome. Aliment Pharmacol Ther 20(Suppl 3):57–62
Haussinger D, Schliess F (2008) Pathogenetic mechanisms of hepatic encephalopathy. Gut 57:1156–1165
Kjaergard LL et al (2003) Artificial and bioartificial support systems for acute and acute-on-chronic liver failure: A systematic Review. JAMA 289:217–222
Kribben A, Gerken G, Haag S et al (2012) Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure. Gastroenterology 142(782–789):e–3
Kurschat C, Grundmann F Benzing T (2010) Das hepatorenals Syndrom. Intensivmedizin up2date 6:41–50
Lerschmacher O, Koch A et al. (2013) Management der dekompensierten Leberzirrhose auf der Intensivstation. Med Klin Intensivmed Notfallmed. Epub ahead of print
Mitzner SR et al (2002) Extracorporeal support of the failing liver. Curr Opin Crit Care 8:171–177
Mitzner SR, Stange J, Klammt S et al. (2000) Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transpl 6:277–286
Ostapowicz G, Fontana RJ, Schiodt FV et al (2002) Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 137:947–954
Rademacher S, Oppert M, Jörres A (2011) Artificial extracorporeal liver support therapy in patients with severe liver failure. Expert Rev Gastroenterol Hepatol 5:591–599
Ruiz-del-Arbol L, Monescillo A, Arocena C et al (2005) Circulatory function and hepatorenal syndrome in cirrhosis. Hepatology 42:439–447
Sagi SV, Mittal S, Kasturi KS et al (2010) Terlipressin therapy for reversal of type 1 hepatorenal syndrome: a metaanalysis of randomized controlled trials. J Gastroenterol Hepatol 25:880–885
Schmidt LE et al (2003) Systemic hemodynamic effects of treatment with molecular adsorbents recirculating system in patients with hyperacute liver failure: A prospective controlled trial. Liver Transpl 3:290–297
Sen S et al (2002) Review article: the molecular adsorbents recirculating system (MARS) in liver failure. Aliment Pharmacol Ther 16(Suppl 5):32–38
Sort P, Navasa M, Arroyo V et al (1999) Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 341:403–409
Stange J (2011) Extracorporeal liver support. Organogenesis 7:64–73
Wauters J, Wilmer A (2011) Albumin dialysis: current practice and future options. Liver Int 31:039–012
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Zink, W. (2014). Lebererkrankungen. In: Repetitorium Intensivmedizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-44933-8_17
Download citation
DOI: https://doi.org/10.1007/978-3-642-44933-8_17
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-44932-1
Online ISBN: 978-3-642-44933-8
eBook Packages: Medicine (German Language)